Sponsor content
213 result(s) found, displaying 91 to 100
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Roche Products Pty Ltd - Medicine administration kit, percutaneous, non-medicated, single-use.
-
Prescription medicine registrationActive ingredients: satralizumab.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Prescription medicine registrationActive ingredients: atezolizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HEMLIBRA emicizumab (rch) 60 mg/0.4 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HEMLIBRA emicizumab (rch) 105 mg/0.7 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HEMLIBRA emicizumab (rch) 150 mg/1 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ACTEMRA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, ACTPen Autoinjector.